Short answer: SARMs reach steady blood levels within days, and hormone changes show up within one to three weeks, but measurable muscle gains take weeks. In the trials: LGD-4033 added 1.21 kg of lean mass by day 21 and had already lowered testosterone by then (Basaria 2013); ostarine lowered SHBG and testosterone within 14 days, and added 1.3 kg of lean mass by day 86 (EMERALD protocol, Dalton 2011). For RAD-140, YK11, S23 and andarine there are no human data on when muscle effects start; what users describe is anecdotal.
| Compound | Steady levels | First measured change | Muscle/body change measured |
|---|---|---|---|
| Ostarine | A few days (half-life ~14–24 h) | SHBG and testosterone down by day 14 | +1.3 kg lean mass at day 86 (3 mg/day) |
| LGD-4033 | Builds ~3× over 3 weeks (half-life 24–36 h) | Testosterone, SHBG, HDL down by day 21 | +1.21 kg lean mass at day 21 (1 mg/day) |
| RAD-140 | About a week (half-life ~45 h) | Liver enzymes and SHBG changed in the cancer trial | Never measured in people |
| MK-677 | Daily effect lasts ~24 h | IGF-1 up within 7 days; appetite | +1.1 kg fat-free mass at 12 months (older adults) |
| Cardarine | Not established | Triglycerides, LDL down within 2 weeks | Fat loss never measured |
| Andarine, YK11, S23, SR9009 | Not established | No human data | No human data |
Source: Sarmguide compound database.
Factors Influencing The Time Of Onset
Before we go through each SARM and compound related to SARMs, let’s look at what factors influence the time of onset of SARMs.
Placebo
The mind is an incredible powerful tool, and it can influence the body in unprecedented ways.
Feeling a “pump” or more energy on day one is very likely expectation rather than drug effect: none of these compounds has been shown to change performance in hours. In the 86-day ostarine trial, 17% of people on placebo reported headaches, a reminder of how much people feel regardless of the drug (Dalton 2011).
Route of Administration
It’s all about bioavailability.
If you take a compound and your method of administration allows you to enjoy 100% bioavailability, it will take less time for the compound to start working in your body.
Every human SARM trial used oral dosing, and oral SARMs were well absorbed. Claims that injecting makes them faster or stronger have not been tested, and injecting unregulated products adds infection risk.
You can read more about this topic in my guide to injectable SARMs.
Dosage
In the LGD-4033 trial, blood levels rose in proportion to the dose, and so did the drops in testosterone, SHBG and HDL (Basaria 2013). A higher dose doesn’t mean faster muscle; it means more of every effect, including side effects.
While these effects might not always be positive, as we’ll later see, they’ll be potent and that’s something to take into account before taking astronomical dosages of SARMs.
You’re likelier to experience more side effects on a higher dosage!
Purity
I think that we can all agree that this is the most important factor of them all.
If a product doesn’t contain what the label says, nothing kicks in as expected. In a JAMA test of 44 products sold as SARMs, only 52% contained a SARM, 4 contained no active compound and only 41% matched the label (Van Wagoner 2017). Choose a seller with batch lab reports; our current pick is in the SwissChems review.
SARMs Effects Timeline
For each compound below, what trials measured comes first; the week-by-week descriptions from the original version of this page are user reports and are marked as such.
Ostarine
Measured: half-life about 21–24 hours after one dose; in a 14-day Phase 1 study, SHBG and total testosterone were already lower and ALT rose with dose (EMERALD protocol). Lean mass was 1.3 kg higher than placebo at day 86 on 3 mg a day (Dalton 2011). User reports: headaches in the first week, sometimes insomnia, visible changes from about week two, and signs of suppression around weeks six to seven. More: ostarine fact sheet, ostarine before and after.
Ligandrol
Measured: half-life 24–36 hours, with levels building about threefold over 21 days. By day 21, lean mass was 1.21 kg higher at 1 mg a day, while testosterone, SHBG and HDL had fallen; strength had not changed significantly (Basaria 2013). User reports: water retention from about week one and strength gains from weeks two to three. More: when to take LGD-4033.
RAD 140
Measured: half-life about 45 hours, so levels reach a steady state after roughly a week of daily dosing (LoRusso 2022). How long RAD-140 takes to “kick in” for muscle or strength has never been measured in people. In young male monkeys, 28 days raised body weight by more than 10% and lowered testosterone by about two-thirds (Miller 2011). User reports: strength gains from about 10–15 days, peaking around week four, with suppression felt from about week six. More: RAD-140 before and after.
Andarine
Measured: no human data. Half-life 2.6–5.3 hours in rats (Kearbey 2004). User reports: vision changes (yellow tint, night vision) after about 7–10 days at higher doses; fat loss after two to three weeks. Don’t drive if your vision changes. More: S4 before and after.
YK11
Measured: no human data; half-life not established (Piper 2018). User reports: aggression in week one, strength and size from about week three, lower libido and joint pain around weeks five to six. More: YK11 before and after.
S23
Measured: no human effect data. In rats, LH fell by more than half within 14 days (Jones 2009). User reports: night sweats in week one, strength from about day ten, hair shedding around week five. More: S23 before and after.
Cardarine
Measured: blood-fat changes within 2 weeks at 10 mg a day: triglycerides −30%, LDL −23%, liver fat −20% (Risérus 2008). Fat loss and endurance were never measured in people; endurance gains are from mice. User reports: more endurance from the first day. That early “feeling” has no study behind it. More: cardarine before and after.
MK-677
Measured: IGF-1 rose in a dose-dependent way within 7 days (Copinschi 1996), and nearly doubled by 4 weeks in older adults (Chapman 1996). Increased appetite was the most common side effect; in a 12-month trial, fat-free mass rose 1.1 kg vs a loss on placebo (Nass 2008). Deep sleep and REM sleep increased in a sleep study (Copinschi 1997). User reports: hunger from day one and better sleep early on. Drinking more water has not been shown to prevent its water retention. More: MK-677 fact sheet.
Stenabolic
Measured: no human data. In mice, a single injection shifted daily activity patterns (Solt 2012), and REV-ERB agonists increased wakefulness (Banerjee 2014). User reports: more energy soon after a dose and sleep problems if taken late in the day. More: SR9009 dosage.
Conclusion
When do SARMs kick in? Blood levels within days, hormone changes within one to three weeks, and measurable lean-mass gains of about 1–1.5 kg over three weeks to three months for the two SARMs that have been tested in people. Feeling something on day one is mostly expectation. For RAD-140, YK11, S23, andarine and SR9009, onset times are user reports only. The original author’s main lesson still stands: a higher dose doesn’t make results come faster, but it does make side effects more likely. Timing within the day is covered in best time to take SARMs; compare compounds in the SARMs database.
Frequently asked questions
How long do SARMs take to work?
Days to weeksEvidence: Trial
In trials, hormone changes appeared within one to three weeks, and lean-mass gains of about 1–1.5 kg were measured at 3 weeks (LGD-4033) and about 12 weeks (ostarine). Feeling effects sooner is anecdotal.
How long does RAD-140 take to kick in?
Never measured in peopleEvidence: User reports
With a half-life of about 45 hours, it reaches steady levels after about a week of daily dosing. When muscle or strength effects start has never been measured; users report strength gains from about 10–15 days.
How long does ostarine take to kick in?
Hormone changes within 14 daysEvidence: Trial
Lower SHBG and testosterone were measured within 14 days. In the main trial, lean mass was 1.3 kg higher than placebo at day 86.
How long does cardarine take to work?
Blood fats within 2 weeksEvidence: Trial
Lower triglycerides and LDL were measured within 2 weeks. Fat loss and endurance were never measured in people; early endurance gains are user reports.
When does MK-677 kick in?
IGF-1 up within 7 daysEvidence: Trial
IGF-1 rose within 7 days, and increased appetite was the most common side effect. Changes in fat-free mass were measured over months.
Do higher doses make SARMs work faster?
No evidenceEvidence: Trial
No study shows faster results. In the LGD-4033 trial, higher doses raised blood levels and caused bigger drops in testosterone, SHBG and HDL.
Sources
- The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men
- EMERALD study protocol (ISRCTN12213700, University of Liverpool, version 6.0, 2021): a window of opportunity study of enobosarm in ER+/AR+ early breast cancer
- The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial
- Chemical Composition and Labeling of Substances Marketed as Selective Androgen Receptor Modulators and Sold via the Internet
- A First-in-Human Phase 1 Study of a Novel Selective Androgen Receptor Modulator (SARM), RAD140, in ER+/HER2- Metastatic Breast Cancer
- Design, Synthesis, and Preclinical Characterization of the Selective Androgen Receptor Modulator (SARM) RAD140
- Pharmacokinetics of S-3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro- 3-trifluoromethyl-phenyl)-propionamide in rats, a non-steroidal selective androgen receptor modulator
- Studies on the in vivo metabolism of the SARM YK11: Identification and characterization of metabolites potentially useful for doping controls
- Preclinical characterization of a (S)-N-(4-cyano-3-trifluoromethyl-phenyl)-3-(3-fluoro, 4-chlorophenoxy)-2-hydroxy-2-methyl-propanamide: a selective androgen receptor modulator for hormonal male contraception
- Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men
- Effects of a 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-hour GH profiles, insulin-like growth factor I, and adrenocortical function in normal young men
- Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects
- Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial
- Prolonged oral treatment with MK-677, a novel growth hormone secretagogue, improves sleep quality in man
- Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists
- Pharmacological targeting of the mammalian clock regulates sleep architecture and emotional behaviour